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 The paper focuses on the practice of social prescribing as it is currently implemented 
through the National Health Service (NHS) of the United Kingdom.  Social Prescribing is an 
emerging healthcare intervention aimed at referring patients to community-based activities. NHS 
promotes social prescribing as a method of reducing healthcare utilization in chronically ill 
patients. Current evidence on social prescribing is subject to significant variation and has not 
supported NHS’s claims.  The potential link between feeling of social isolation, loneliness and 
chronic illness was further investigated through data from the National Social Life, Health & 
Aging Project (NSHAP).   Data was tested for correlations between respondents’ self-report of 
heart problems (chi-squared) and systolic blood pressure (Pearson’s correlation), in relation to 
survey measures on subjects’ level of social isolation and loneliness. To control for common 
comorbidities of cardiovascular disease, respondents were excluded if they reported current 
smoking status, diagnosis of diabetes, or waist measurements relating to obesity.  Logistic and 
linear regression was then performed to identify predictive models for self-reported heart 
problems and systolic blood pressure respectively.  The study provides limited evidence for to 
support the impact of social prescribing.  This limitation is driven by the high degree of variation 
amongst reported outcomes.  Future policy initiatives should focus on developing the body of 















Long Term Health Condition- Ongoing illnesses which cannot be cured, but can be effectively 
 
 managed through healthy patient habits and medical intervention.  
 
Loneliness- The subjective feeling of disconnection from those around you.  
 
Social Isolation- The persistent absence of social contact. 
 
Social Prescribing- The process of referring a patient to community-based activities. 
 
List of abbreviations 
 
CVD- Cardiovascular Disease 
EHR- Electronic Health Record 
GP- General Practice/Practitioner 
NHS- National Health Service 
NORC- Non-partisan and Objective Research Organization 
NSHAP- National Social Life, Health & Aging Practice  
OHCA- Out of Hospital Cardiac Arrest 
USCB- United States Census Bureau  
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 Social prescribing is an emerging healthcare practice targeting individuals experiencing 
social isolation and loneliness (NHS, n.d). Through social prescribing programs, healthcare 
professionals can refer patients to a variety of community activities. In the United Kingdom, the 
National Health Service (NHS) has begun developing infrastructure within general practices to 
facilitate social prescribing.  The NHS suggests that social prescribing can benefit individuals 
experiencing an array of long-term health conditions (NHS, nd).  However, the specific 
conditions that can be addressed remain unclear.  There is also confusion regarding the 
directionality of potential interactions between social isolation, loneliness, and chronic health 
outcomes.  Do these negative social experiences negatively impact one’s health, or does poor 
health promote negative social experiences?  There is value in understanding these dynamics 
when analyzing social prescribing’s reported ability to decrease healthcare utilization (Sheffield, 
2014).   
 The NHS’s claims on the efficacy of social prescribing warrant further investigation.  
Genuine questions remain regarding who can benefit from the service. This paper will attempt to 
analyze this issue through two methods.  The first is a comprehensive review of current literature 
and practice of social prescribing.  The second is a statistical analysis of the relationships 
between social isolation, loneliness and outcomes associated with the long-term health condition, 
cardiovascular disease (CVD).  Through this analysis the paper aims to determine whether CVD 
patients are at higher risk for experiencing social isolation and loneliness. Through assessing 
these items, the paper will attempt to describe the current understanding of social prescribing as 
an intervention for long term health conditions.    
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Social Prescribing Background 
 Social prescribing is an emerging practice targeting lonely and socially isolated 
individuals.  Through social prescribing, healthcare providers refer clients to community-based 
activities. (Ewbank, 2020) The aim of social prescribing is to address patient care holistically.  
This means viewing a patient’s health in the context of their specific needs and abilities. 
(Ewbank, 2020) Social prescribing patients attend community-based programs focusing on 
topics such as: volunteering, performing arts, group learning, cooking, and physical activity. The 
nature of the activities one attends is based heavily on the patients stated goals, abilities, and 
motivation.   
 While social prescribing programs have existed in the United Kingdom since the 1980s, 
the last decade has seen the NHS formally integrate these programs into General Practice (GP) 
systems (Ewbank, 2020). NHS’s Five Year Forward Review, (NHS, 2014) laid out a roadmap for 
developing new models of care.  The report emphasized the need for new, patient-centered 
programs.  The NHS hoped to utilize this novel treatment intervention to reduce overall burden 
on the healthcare system. (NHS, 2014) The NHS review highlighted a social prescribing pilot 
program in Rotherham. The program was noted for its ability to reduce out-patient appointments 
and hospital admissions.   
 In 2019, the NHS under the Universal Personalized Care program, began incorporating 
social prescribing in its general practice system (NHS, nd.). The link worker is a non-clinical 
role, focused on connecting clients with appropriate social prescribing programs. Link workers 
typically receive clients through referral from a GP and meet with individuals over a 3-month 
period consisting of approximately 6 individual sessions. (NHS, nd.)  During these meetings the 
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link worker helps the individual identify appropriate community programs based on their stated 
treatment goals. The NHS aims to recruit 1,000 link workers by 2021, with the goal of serving up 
to 900,000 patients by 2024.  (NHS. Nd.) 
 Social prescribing programs can receive funding through a variety of sources.  This can 
include funding through Clinical Commissioning groups, local governments, and grants (Polley 
et al., n.d.). There are no clear guidelines for how this funding should be deployed.  Individual 
social prescribing schemes can make decisions on allocating funding based on the needs of their 
community.  The current NHS contract secures five years of funding for primary care networks 
serving at least 30,000 patients to employ a full-time link worker (Ewbank, 2020).  It is difficult 
to obtain clear estimates for the offsetting of cost through reduced healthcare utilization. 
Additionally, £5 million ($6.95 million USD) of funding has been allocated to establish a 
National Academy of Social Prescribing. The academy is tasked with developing standardized 
models of social prescribing, best practice standards and accreditation guidelines (Department of 
Health and Social Care, 2019).    
Social prescribing in practice 
 The Rotherham pilot program was commissioned by NHS Rotherham in 2012.  The pilot  
 
received £1.1 million ($1.53 million USD) in grant funding through the NHS covering a period  
 
of two years. Approximately 56% of the program were allocated for developing a roster of  
 
Voluntary and Community Sector (VCS) activities. The remaining 44% was used for program  
 
cost related to developing and running the pilot.   The pilot offered a total of 31 services 
 
provided by 24 unique organizations. A total of 30 GP sites participated in the pilot.  The pilot  
 
cohort consisted of 1,607 patients, 87% of the pilot cohort were age 60 or older.  Females  
 
comprised 61% of the pilot cohort (39% Male), while whites accounted for 91% of the cohort.   
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The most popular programs focused on information and advice (n=248), community activity  
 
(n=246), physical activity (n=172), and befriending (n=167).  1,118 patients were referred to a  
 
funded VCS and the remainder were referred to non-funded services.  
 
 After six months patients saw a 14% overall reduction in inpatient admissions.  For  
 
patients who participated in the program for one year, overall inpatient admissions were reduced  
 
by 21%.  27% of patients referred to a funded VCS for six months saw a reduction in inpatient  
 
services. This reduction in inpatient admissions was seen in 48% of patients referred to a funded  
 
VCS for one year.  For the six-month group 30% of patients referred to a funded VCS saw a  
 
reduction in outpatient appointments.  In the one-year group, 55% of patients referred to a  
 
funded VCS experienced a reduction in outpatient appointments.  
 
 One shortcoming of the Rotherham pilot is the lack of reporting on patient diagnoses, and  
 
corresponding services utilized.  The results were based on the entire cohort which received  
 
differing services for a multitude of reasons.  One could argue that this heterogeneity  
 
supports the notion that social prescribing is responsible for the observed outcomes.  However,  
 
there is also evidence that this heterogeneity could skew observed results as well.  Another social  
 
prescribing program in South Devon (N=151) found that mean healthcare cost rose by 66.7%,  
 
despite overall measures of quality of life saw improvement.  This result was attributed to 12  
 
medically frail individuals who saw marked declines in health over the study period. This  
 
outcome highlight the fact that in heterogeneous samples, there may be underlying trends which  
 
influence the final results.  The identification of such trends can help researchers understand  
 
when social prescribing is beneficial, and when it isn’t.  Following up on the South Devon data,   
 
one may ask whether the social prescribing program influenced the subject worsening health.    
 





Healthcare Utilization   
 
 While the Rotherham pilot program reported significant decreases in healthcare  
 
utilization, the broader body of evidence is less clear.  Previous research has reported reductions  
 
ranging from 2% to 70% in care utilization (Polley et al., 2017).   As described above, these  
 
results could be attributed to the wide variance in both patients referred and services offered.   
 
Furthermore, studies following individual cohorts from a single GP or social prescribing  
 
program are likely to have a low number of subjects.  Even within these small cohorts, subjects  
 
are likely to referred to a variety of activities for varying conditions (Mason et al., 2019). This  
 
limits our ability to draw meaningful conclusions from their data (Loftus et al., 2017).  
 
However, in one study was found (Polley et al., 2019) in which subjects were organized with a  
 
case-matched control groups based on diagnosis of cardiovascular disease, age and gender  
 




What is Successful Social Prescribing?  
 The variability in program design and reported outcomes, leaves doubt regarding what 
“successful” social prescribing is. The NHS has designed its social prescribing initiatives around 
the guiding principle that patients should be active participants in the planning and delivery of 
their care.  Central to this principle is an acknowledgement of the patient’s values and goals.   
Currently, the best practice for “successful” outcomes may be to focus on the patient-centered 
nature of the treatment.  Evidence suggests that patients are more likely to participate in a social 
prescribing program when they enter with positive attitudes and expectations (Husk et al., 2019).  
Attitudes promoting participation include dissatisfaction with one’s current treatment 
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interventions and the belief that social prescribing could positively affect their condition.  It 
could be that patients that enter treatment with positive expectations may be more aware of 
positive changes they experience.   
Barriers 
 Given the novelty of social prescribing schemes, some GPs may lack the  
 
understanding or resources to begin referring patients.  For example, GPs may be unfamiliar with  
 
their communities’ resources.  The role of the link worker is intended fill this gap in information,  
 
but some GPs may not feel confident with the link worker’s level of training of expertise.   
 
Additionally, the lack of evidence-based standards may make conversations about treatment  
 
course and benefits difficult for GPs (Fixsen, et al., 2020).  As a result, GPs may avoid  
 
discussing social prescribing in favor of more familiar medical interventions.  The local contexts  
 
of social prescribing programs have hindered the development of standardized models of  
 
evaluation. (Husk et al., 2019) Social prescribing referrals are inherently limited to what is  
 
available in the community.  As a result, patients can receive significantly different services at  
 
varied intervals.   
 
Social Isolation vs. Loneliness 
 While social isolation and loneliness are at times used interchangeably, the two have 
meaningful differences.  Social Isolation refers to the objective absence of human contact 
(Veazie et al., 2019). Alternatively, loneliness is the subjective feeling of alienation from those 
around them.  Effectively, loneliness is the perception that one is socially isolated. (Donovan & 
Blazer, 2020) While both experiences can, and often do, occur simultaneously, they are not 
synonymous.  One can interact with multiple people each day, but feel they have no one to “open 
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up to.”  Conversely, an individual may spend long periods of time at home alone but are still 
satisfied with the time they do get to spend with friends and family.   
 From the perspective of healthcare, it is a worthwhile to distinguish between the above 
experiences.  Both experiences have the potential to negatively influence one’s health in unique 
ways.  The lonely individual may be at higher risk for increased stress and worse mental health.  
The socially isolated individual may fail to get adequate physical activity.  They could also 
struggle to meet their basic needs, when doing so requires travel outside the home.  Each 
individual has unique needs that may be amenable to treatment.   
Social isolation, Loneliness, and Health  
 Valtorta et al. (2018) examined Cardiovascular Disease (CVD) in the context of both 
social isolation and loneliness.  The 6-year longitudinal study found that while social isolation 
was not associated with increased risk of CVD, self-reported loneliness was.  This was true of 
any individual who reported loneliness over the 6-year period.  The frequency of reported 
loneliness was not found to have a cumulative effect on CVD risk.      
 There is evidence linking social isolation and loneliness to mortality (Holt-Lunstad et al., 
2015).  The nature of their interaction is unclear.  There is some evidence that individuals who 
are both socially isolated and lonely have a significantly higher risk of mortality, compared to 
individuals who endorse only one experience (Beller et al., 2018). Conversely, other literature  
supports that social isolation has the greatest risk of all-cause mortality (Steptoe et al., 2013).   In 
the context of CVD, social isolation was not found to correlate with risk of developing CVD, but 
was found to increase the risk of mortality following a cardiac event (Smith et al., 2021) .It is 
important to note that this trend was only present in individuals who were not admitted to the 
hospital following the event.   
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 These results suggest that social isolation may not directly impact the development or 
progression of CVD.  Instead, socially isolation may increase risk for complications from CVD 
due to a lack of access to immediate help.  If an individual spends large amounts of time alone, 
they are less likely to have someone near to administer aid during a cardiac event.   Out of 
Hospital Cardiac Arrest (OHCA) accounts for 70% of all instances of cardiac arrests in the 
United States.  (Heart.org, n.d.)  Immediate intervention through bystander Cardiopulmonary 
Resuscitation is a significant predictor of survival.  (Vierek, 2017) Socially isolated individuals 
are less likely have someone available to administer these services in the event of an acute 
cardiac event.  
Methods 
Data Source 
 The data used in this study originated from the National Social Life, Health & Aging 
Project (NSHAP) (NSHAP, nd).  NSHAP is conducted through the non-partisan and objective 
research organization (NORC) at the University of Chicago.  NSHAP is a multidimensional 
longitudinal study focused on older adults in the United States.  Data from three cohort waves 
have been collected thus far, Cohort One Wave One (C1W1) 2005-2006, Cohort One Wave Two 
(C1W2) 2010-2011, and Cohort One Wave Three (C1W3) 2015-2016.  This study used data 
obtained from C1W3 consisting of 4,777 total subjects. Data was collected through in-person 
interviews, recording of biological measures, and supplement leave behind questionaries.  The R 




 The mean age for all participants was 67.63.  For males the mean age was 67.57.  For 
females the mean age was 67.69.  The study consisted of 2,374 female participants and 2,003 
male participants. 3,194 participants identified as White, 719 participants identified as Black, and 
452 identified as Asian, Pacific Islander, American Indian or Alaskan native.  2,755 participants 
reported being married (Male=1,461, Female=1,294).  149 unmarried participants reported living 
with a partner (Male=66, Female=73).  For the purpose of the statistical analysis, individuals 
who reported current smoking status, diagnosis of diabetes, or waist diameter above a certain 
threshold (males=40in, females=34.5, males & females combined=37.25).  After adjusting for 
these variables the analysis consisted of 256 females, 235 males, and 547 for the combined male 
and female group.  
Variable Selection 
 Dependent variables were categorized as relating either to social isolation or loneliness.  
Items that referenced objective measures regarding frequency of interaction with others and daily 
levels of activity, were categorized as pertaining to Social Isolation. These measures included 
items such as, marital or relationship status, and frequency of attending organized events (Table 
1). In total 7 items were categorized as relating to social isolation.  Social isolation items were 
presented as ratings of the frequency of an activity, ranging from 0 (never) to 6 (several times a 
week).  Exceptions to this format were marital status which ranged from 1 (married) to 6 (never 
married).  Items that referenced the subject’s subjective feelings on their relationships were 
categorized as pertaining to loneliness (Table 2).  All loneliness variables were also presented on 
a Likert scale ranging from 0 (never) to 3 (often).    
 Two measures relating to participants’ cardiovascular health were used as dependent 
variables.  The first was the subject’s self-report of having been told by a doctor that they have a 
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heart problem.  This measure did not ask the subject to disclose the exact nature of the heart 
problem. The definition of “doctor” excluded chiropractors, dentists, nurses, and nurse 
practitioners.   The second variable was the participants systolic blood pressure. Blood pressure 
was in two separate instances.  For this analysis the systolic blood pressure from the second 
reading was used.   To account for comorbidities associated with CVD, three control variables 
were identified, weight, diabetes diagnosis, and smoking status.   
Social Isolation Variables 
Variable Definition 
Marital Status Current Marital Status 
Romantic 
Partner Current Relationship Status (if unmarried)  
Volunteering Frequency of volunteering in the past year 
Attending 
groups/events Frequency of attending organized meetings in the past year 
Socializing Frequency of socializing with friends and/or family in the last year 
Attending 
services Frequency of attending religious services in the past year 
Table 1 The variables categorized as addressing social isolation, and corresponding definitions  
 
Loneliness Variables  
Variable Definition 
Left Out* How often do you feel left out? 
Isolated *+ How often do you feel isolated? 
Companion* How often do you feel you lack companionship? 
Family 
openness How often can you open up to family? 
Friends 
openness  How often can you open up to friends? 
Family 
Understanding  How often does family understand how you feel? 
Friends 
Understanding How often do friends understand how you feel?  
Happiness Self-rated happiness 
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Table 2 The variables categorized as addressing loneliness. (*) Variables comprising the UCLA 
loneliness scale. (+) Refers to the subjects’ subjective feelings of isolation, thus was coded as relating 





 Chi-squared tests were used to analyze the relationship between subjects’ self-reported 
heart problems and the designated social isolation and loneliness variables.  Pearson’s correlation 
was used to compare the variable of systolic blood pressure to the social isolation and loneliness 
variables.   Analysis was performed for the entire sample, as well as male and female subgroups.   
To control for cardiovascular disease comorbidities, smokers, diabetics, and respondents above a 
certain waist size were removed. Logistic and linear regression were used to identify potential 
predictive models for variables that reached statistical significance in the previous analysis.   
Statistically significant variables underwent logistic regression or linear regression for self-
reported heart problems and systolic blood pressure respectively.   All statistical analysis was 
performed using R Studio version 1.2.5033 run on MacOS version 10.15.7.    
Results 
 
Heart problems and social isolation 
 
 The chi-squared analysis for the male and female group revealed significant relationships  
 
between physical activity (X2(5) = 16.90, p= 4.69e-3), volunteering (X2(6) = 18.33, p= 0.01), and  
 
self-reported heart problems.  A logistic regression analysis was performed to assess  
 
the relationship between physical activity and self-reported heart problems for both females, and  
 
the combined male and female group (p= 1.38e-3) with R2=0.08.  Males and females predicted  
 
likelihood of a reported heart problem is equal to -1.18-1.12(<once per month)-16.39(1-3 times  
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per month)-1.11(1-2 times per week)-1.07(3-4 times per week)-1.36(> 5 times per week).  A  
 






Chi-squared results Heart Problems and Social Isolation 
Variable df X2 p-value 
Male and female     
Physical Activity 5 16.9 4.69E-03 
Volunteering 6 18.33 0.01 
Table 3 Measures of social isolation which reached significance after controlling for 
confounding variables.  
 
 
Heart problems and loneliness 
 
 The chi-squared analysis revealed several significant interactions between self-reported  
 
heart problems and measures of loneliness, happiness for males (X2(4) = 11.05, p= 0.03),  
 
feelings of isolation for females (X2(3) = 11.80, p= 0.01), and feelings of isolated for both males  
 
and females (X2(3) = 17.95, p= 4.52e-04).  A logistic regression analysis was performed to assess  
 
the relationship between self-reported feelings of isolation and self-reported heart problem for  
 
both females, and the combined male and female group. A significant logistic equation was  
 
identified for males and females, (p=0.01) with an R2=0.05. Males and females predicted  
 
likelihood of a reported heart problem is equal to -2.56-.022(Hardly ever feels  
 
isolated)+0.54(Sometimes feels isolated)+ 2.09(Often feels isolated).  A logistic regression  
 
analysis for self-reported heart problems and males’ happiness failed to reach significance.   
 
Likewise, the logistic regression for females self-reported feelings of isolation and self-reported  
 













   
Chi-squared results Heart Problems and Loneliness 
Variable df X2 p-value 
Male     
Happiness 4 11.05 0.03 
      
Female     
Feeling Isolated 3 11.8 0.01 
      
Combined      
Feeling Isolated 3 17.95 4.52E-04 
 
Table 4 Loneliness variables which reached statistical  
Significance after controlling for confounding variables.  
 
Systolic blood pressure and social isolation 
 
 Results of the Pearson’s correlation analysis revealed two significant relationships for  
 
systolic blood pressure.  For males, marital status was found to be significant (r= 0.16, p=0.02).   
 
For both males and females, attending religious services was found to be significant (r=-0.009,  
 
p=0.05). Neither variable was able to produce a statistically significant linear model.   
 
 
Pearson's correlation results for Systolic Blood 
Pressure and Social Isolation   
Variable  r p-value  
Male      
Marital Status 0.16 0.02  
     
 
Combined    
 
Attending Services -0.009 0.049  
 





Systolic blood pressure and loneliness 
 
  Results of the Pearson’s correlation analysis revealed two significant relationships for  
 
systolic blood pressure.  For males, happiness was found to be significant (r= -0.18, p=0.01).   
 
For females, feeling isolated services was found to be significant (r=-0.17, p=0.01).  No  
 
significant relationships were found within the male and female groups. A simple linear  
 
regression was calculated to predict Systolic blood pressure based on males’ happiness.  This  
 
model failed to reach statistical significance.  A second linear regression was calculated to  
 
predict systolic blood pressure based on females’ feelings of isolation. For this relationship a  
 
significant regression equation was found (F(3,204)=3.265, p=0.02), with an R2 of 0.03.  
 
Females’ predicted weight is equal to 126.32-6.96(Hardly ever isolated)-9.60(Sometimes  
 
isolated)+0.43 (Often isolated). 
 
Pearson's correlation results for Systolic Blood 
Pressure and Loneliness  
Variable  r p-value  
Male      
Happiness -0.18 0.01  
Female    
 
 Isolated -0.17 0.01  





 This study had a number of limitations. The self-reported measure of heart problems may  
 
have been too broad.  The only criteria offered to respondents was that they had been given this  
 
information from a medical doctor.  Respondents could have under or over reported heart  
 
problems based on how they interpreted the question, and information they received from their  
 
GP.  A more conclusive comparison could use specific diagnoses from medical records or  
 
claims.  The Likert scale ratings for loneliness are also subject to interpretation.  Phrases such as  
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‘often” and “some of the time” could be interpreted drastically differently from subject to  
 
subject.  A more effective measure may reframe the items in terms of satisfaction with these  
 






 The results of the data analysis offered inconsistent support for a relationship between  
 
cardiovascular disease and measures of social isolation and loneliness.  Males showed limited  
 
correlation between social isolation and loneliness measures and both heart health variables.  
 
Furthermore, variables that were found to be significant typically focused on measures such  
 
as marital status and general happiness.   Variables which included more specific measures of  
 
time spent on social activities and feelings on one’s relationships were predominately non- 
 
significant.   The only exception to this trend was the relationship between volunteering and self- 
 
reported heart problems, prior to accounting for controls, and one’s families’ understanding their  
 
feelings after accounting for controls.  Prior to accounting for controls women’s measures of  
 
heart health correlated with a wider range of social isolation and loneliness measures.   
 
 These data, along with the existing body of literature, suggests the greatest barrier to  
 
implementing effective social prescribing is the lack of consistent, validated evidence.   The  
 
current evidence provides the strongest support for utilizing social prescribing only as a  
 
supplement to traditional care when it aligns with the patient’s goals.  GPs should be cautious not  
 
to overstate the potential health benefits to the patient.   
 
 NHS should take steps to improve the quality of evidence surrounding social prescribing.   
 
Funding and resources may better spent on policy initiatives such as the National Academy of  
 
Social Prescribing, than in the development of individual programs.  A greater body of evidence  
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would help government and healthcare officials make more informed choices regarding future  
 
funding initiatives.  Under the NHS’s current trajectory, there is a risk of developing  
 
infrastructure and resources that ultimately do not fulfil their intended purpose. The NHS may  
 
find that considerable funding has been spent on resources that fail to produce benefits in patient  
 
outcomes or cost control.   
 
 This goal could be further aided by establishing a national database of social prescribing  
 
Patients through electronic health records (EHR).  This database could help fill in gaps of  
 
information which limit current research.  An effective database should account for information  
 
including, demographics, geographic location, diagnosis, program referrals, and program  
 
attendance.  Such a database could improve research design by allowing for larger cohorts  
 




 Social prescribing is a novel form of healthcare that attempts to address patients’ health  
 
issues while promoting socialization and general well-being.  The NHS has made considerable  
 
efforts to build-out social prescribing infrastructure. While GPs are being encouraged to promote  
 
the practice with their patients, the poor evidence base remains a barrier to effective utilization.   
 
Questions remain regarding whether chronic illnesses can be positively impacted by social  
 
prescribing.  The efficacy of individual social prescribing activities also requires further analysis.   
 
The NHS has ambitious goals for expanding its social prescribing programs. However, these  
 
efforts appear premature given the lack of evidence supporting them.  To develop an effective  
 
social prescribing program, current efforts should be focused on refining the means of data  
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